ArticleBMC research notes2025
Challenges in assessing self-reported adherence to antiretroviral therapy among individuals living with HIV/AIDS and mental disorders.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Studies focusing on individuals living with HIV and mental disorders are crucial to inform and enhance care for this inherently vulnerable population group, especially considering that people living with HIV/AIDS (PLHIV) are more likely to develop mental disorders compared to the general population, contributing to lower adherence to antiretroviral therapy (ART). This study cross-sectional study aimed to assess self-reported adherence to antiretroviral therapy among PLHIV and moderate or severe mental disorders in Campo Grande, Mato Grosso do Sul, Brazil. Patient-reported data from PLHIV who received care in at least one of the Psychosocial Care Network facilities of the Brazilian Unified Health System from 2014 to 2018 were collected to assess the adherence to ART. Among the 76 participants eligible, 35 were included in the study. Substance use-related mental disorders were the most prevalent (45.7%), followed by mood disorders (25.7%) and anxiety (11.4%). Most of the participants had a low ART adherence (62.9%), followed by insufficient adherence (22.9%) and good adherence (14.3%). No significant associations were found between the adherence to ART and the study variables. Our findings suggest the importance of assessing adherence based on both direct and indirect measures, as biological markers and self-report.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.